Lung Cancer Treatment Plans Changed Due to Pandemic
57 percent of patients receiving active treatment had at least one change in treatment plans
Spironolactone Not Tied to Breast Cancer Recurrence
Drug can be used for alopecia treatment in breast cancer survivors
Many Doctors Misinformed About Nicotine’s Risks
Less than one-third of doctors correctly agree that nicotine directly contributed to birth defects
PPI Use Is Negative Prognostic Marker in Urothelial Cancer
PPI use linked to significantly worse progression-free, overall survival in advanced urothelial cancer
Ultrasound Ablation Offers Option for Some With Prostate Cancer
Bilateral prostate cancer at diagnosis was sole predictor of Grade Group 2 or greater recurrence
Darolutamide Boosts Survival in Nonmetastatic Prostate Cancer
Risk for death significantly lower versus placebo in nonmetastatic, castration-resistant prostate cancer
Factor V Activity Significantly Increased in Severe COVID-19
Rates of DVT/PE significantly higher for patients with COVID-19 and elevated factor V activity
Eflornithine + Sulindac Shows No Benefit in Adenomatous Polyposis
Incidence of disease progression not significantly lower with combo versus either drug alone
NIH Launches Clinical Trials of Antithrombotics for COVID-19
Adaptive design allows evaluation of various doses, types of blood thinners in outpatients, inpatients
HPV Vaccination Rates Increasing Among 15-Year-Olds
Proportion of one- or two-dose HPV vaccination increased from 2011 to 2017; still falling short of goals
